Chen et al. (69) observed increased expression of ACSL4 protein in the MCAO mouse model, and rosiglitazone inhibited its activity and regulated ferroptosis, thus promoting the recovery of neurologic function after stroke. The gene discussed is ACSL4; the disease is stroke disorder.